IMMUNOREGULATORY EFFECTS OF CONVERSION FROM TACROLIMUS TO SIROLIMUS IN LIVER TRANSPLANT RECIPIENTS

被引:0
|
作者
Levitsky, Josh [1 ]
Mathew, James M. [1 ]
Flaa, Catherine W. [1 ]
Rosen, Anne [1 ]
Tambur, Anat R. [1 ]
Miller, Joshua [1 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
553
引用
收藏
页码:568A / 568A
页数:1
相关论文
共 50 条
  • [1] SYSTEMIC IMMUNOREGULATORY EFFECTS OF TACROLIMUS TO SIROLIMUS CONVERSION IN LIVER TRANSPLANT RECIPIENTS
    Levitsky, Josh
    Miller, Joshua
    Tambur, Anat R.
    Abdul-Nabi, Anmaar
    Yang, Guang-Yu
    Chandrasekaran, Dhivya
    Herrera, Nancy
    Al-Saden, Patrice C.
    Mathew, James M.
    [J]. HEPATOLOGY, 2011, 54 : 637A - 637A
  • [2] Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipients
    Levitsky, Josh
    Mathew, James M.
    Abecassis, Michael
    Tambur, Anat
    Leventhal, Joseph
    Chandrasekaran, Dhivya
    Herrera, Nancy
    Al-Saden, Patrice
    Gallon, Lorenzo
    Abdul-Nabi, Anmaar
    Yang, Guang-Yu
    Kurian, Sunil M.
    Salomon, Daniel R.
    Miller, Joshua
    [J]. HEPATOLOGY, 2013, 57 (01) : 239 - 248
  • [3] Evaluation of the Conversion from Tacrolimus to Sirolimus in Liver Transplant Recipients
    Bakhtiari, H.
    Todd, S.
    Snyder, H.
    Lo, D.
    Flynn, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 759 - 759
  • [4] Measured Renal Function in Pediatric Liver Transplant Recipients After Their Conversion From Tacrolimus to Sirolimus.
    Andrews, W.
    Hendrickson, R.
    Fioravanti, V.
    Fisher, R.
    Ricks, S.
    Daniel, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 717 - 717
  • [5] Measured Renal Function in Pediatric Liver Transplant Recipients After Their Conversion From Tacrolimus to Sirolimus.
    Andrews, W.
    Hendrickson, R.
    Fioravanti, V.
    Fisher, R.
    Ricks, S.
    Daniel, J.
    [J]. TRANSPLANTATION, 2014, 98 : 717 - 717
  • [6] Conversion from cyclosporin to tacrolimus in paediatric liver transplant recipients
    Mazariegos G.V.
    Salzedas A.A.
    Jain A.
    Reyes J.
    [J]. Paediatric Drugs, 2001, 3 (9): : 661 - 672
  • [7] Conversion from tacrolimus to Neoral in liver and kidney transplant recipients
    Ott, R
    Bussenius-Kammerer, M
    Scholz, D
    Neuhaus, R
    Tolba, RH
    Fricke, L
    Müller, V
    [J]. TRANSPLANTATION PROCEEDINGS, 2001, 33 (7-8) : 3166 - 3168
  • [8] Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy
    Daniel, J.
    Fioravanti, V.
    Fischer, R.
    Hendrickson, R.
    Ricks, S.
    Davis, M.
    Andrews, W.
    [J]. TRANSPLANTATION, 2014, 98 : 239 - 240
  • [9] Conversion From Tacrolimus (TAC) to Sirolimus (SLR)-Based Immunosuppression in Pediatric Liver Transplant Recipients: Indications and Efficacy
    Daniel, J.
    Fioravanti, V.
    Fischer, R.
    Hendrickson, R.
    Ricks, S.
    Davis, M.
    Andrews, W.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 239 - 240
  • [10] Estimation of a Tacrolimus to Sirolimus Dose Conversion Ratio in Kidney Transplant Recipients
    Kim, M.
    Mandelbrot, D.
    Rogers, C.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 303 - 304